, Tracking Stock Market Picks
Enter Symbol:
Anadys Pharmaceuticals, Inc. (ANDS) [hlAlert]

up 85.92 %

Anadys Pharmaceuticals, Inc. (ANDS) rated Buy with price target $4.50 by Noble Financial

Posted on: Monday,  Nov 24, 2008  10:25 AM ET by Noble Financial

Noble Financial rated Buy Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) on 11/24/2008, when the stock price was $1.99. Since
then, Anadys Pharmaceuticals, Inc. has gained 85.93% as of 11/23/2011's recent price of $3.70.
If you would have followed this Noble Financial's recommendation on ANDS, you would have gained 85.92% of your investment in 1094 days.

Anadys Pharmaceuticals, Inc., is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small molecule medicines for the treatment of viral diseases and cancer. The Company's programs focus on Toll-Like Receptor-based small molecule product candidates and direct antiviral compounds that inhibit key steps in viral proliferation. The Company has core expertise in medicinal chemistry coupled with structure-based drug design, and is developing compounds for the treatment of hepatitis C infection, hepatitis B infection and cancer.

A clear and concise focus. Identifying the emerging small or micro cap company. Recognizing the entrepreneurial character and organizational commitment of its executives and employees. Observing unstoppable drive to exploit opportunities while tackling obstacles. Understanding the company's essential products, services and technologies. Following only those who deserve our attention.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/24/2008 10:25 AM Buy
1.99 4.50
as of 12/24/2008
1 Week down  -51.65 %
1 Month up  86.62 %
3 Months up  86.62 %
1 YTD up  86.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy